Opportunity Information: Apply for PAR 10 208
Apply for PAR 10 208
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213 Research and Training in Complementary and Integrative Health 93.393 Cancer Cause and Prevention Research 93.396 Cancer Biology Research.
- This funding opportunity was created on Mar 15, 2011 and posted on May 27, 2010.
- Applicants must submit their applications by Mar 15, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Private institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments.
- Other Eligible Applicants include the following Eligible Agencies of the Federal Government Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH grant opportunity "The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01)" (Funding Opportunity Number PAR 10-208) is a cooperative agreement program led by the National Cancer Institute (NCI) in partnership with the National Center for Complementary and Alternative Medicine (NCCAM; now known as NCCIH). Its central focus is the biology that sits at the intersection of diet, the gut microbiome, and cancer: specifically, how metabolites produced by gut microorganisms from dietary components influence host cells and, ultimately, cancer risk, prevention, and disparities.
The scientific purpose is to support projects that identify and characterize microbially generated metabolites that come from foods or dietary compounds and then determine how those metabolites act in the body at a molecular and cellular level. The FOA emphasizes mechanistic work on how these bacterial metabolites affect key host processes tied to carcinogenesis and cancer prevention, including cell proliferation and apoptosis (how cells grow and how they undergo programmed cell death), cytokine production (chemical signaling involved in immune responses), and broader inflammatory and immunomodulatory pathways. In practical terms, applicants are expected to go beyond cataloging which metabolites exist and instead explain what they do, what pathways they trigger or inhibit, and how those effects could plausibly increase cancer risk or contribute to prevention.
A major component of the announcement is an encouragement to include human intervention research where appropriate. The FOA highlights the importance of studying inter-individual variability in the production of bacterial metabolites, with explicit attention to differences across racial and ethnic groups. This emphasis ties directly to cancer health disparities: the program is interested in whether different populations produce different levels or profiles of microbial metabolites from the same dietary inputs, and whether those differences translate into different protective or harmful effects relevant to cancer. The long-term implication is to help determine who might benefit from specific dietary recommendations, who might not respond as well, and who could even be put at risk by certain dietary patterns depending on microbiome-mediated metabolism.
The program is also structured to push team science. Applications are required to use a multiple principal investigator model with investigators bringing distinct and complementary expertise. The FOA lists example areas that should be represented across the leadership team, such as microbiology, nutrition, cancer biology, analytical chemistry, and genetics. This requirement reflects the reality that the research spans several technical domains: microbiome studies and culturing or community profiling, metabolite identification and quantification (often requiring sophisticated analytical chemistry and metabolomics platforms), mechanistic testing in cell and animal systems, and human study design and interpretation, including population variation and disparities-related expertise.
From a project design standpoint, the FOA allows either clinical or preclinical approaches, which means applicants can propose human studies, animal models, cell-based mechanistic work, or integrated designs that connect these layers. What matters most is that the work directly addresses the core goal of linking microbial metabolism of diet-derived components to host biological responses relevant to cancer etiology and prevention, and that it is capable of producing actionable mechanistic insight rather than purely descriptive associations.
In terms of award mechanism and oversight, this FOA uses the NIH U01 cooperative agreement mechanism. A U01 is different from a standard research project grant in that NIH staff typically have a more active programmatic role, and the award is intended to function as a partnership between the investigators and the NIH. Consistent with that cooperative structure, the FOA requires investigators to attend annual meetings with NIH personnel, which are generally used to share progress, harmonize approaches across funded teams, and promote collaboration and cross-fertilization of methods and findings.
Eligibility is broad and includes many common applicant types: public and private institutions of higher education, state governments, for-profit organizations (including small businesses and other for-profits), and nonprofit organizations (including those with or without 501(c)(3) status, with certain distinctions). The FOA also notes additional eligible applicants such as eligible federal agencies, non-U.S. (foreign) entities, and regional organizations, indicating an openness to international participation where appropriate. There is no cost sharing or matching requirement listed.
Administratively, the opportunity is categorized as discretionary funding and sits within NIH activity areas that map to complementary and integrative health research and to cancer cause, prevention, and cancer biology research (CFDA numbers listed include 93.213, 93.393, and 93.396). Awards under the FOA are contingent on available funds and the receipt of a sufficient number of strong applications, which is standard NIH language signaling that funding levels and the number of awards depend on both budget and peer review outcomes. The original public posting date is May 27, 2010, and the FOA is now archived, but the content captures the program goals and expectations for applications submitted during its active period.
Overall, this FOA is aimed at building a clearer, mechanistic understanding of how gut microbes transform dietary components into metabolites that can change inflammation, immune signaling, and cell fate decisions in ways that matter for cancer. It is equally focused on translating that biology into prevention-relevant knowledge, including rigorously examining variability across individuals and populations so that dietary guidance and prevention strategies can be better targeted, more effective, and less likely to unintentionally widen health disparities.
Frequently Asked Questions (FAQs)
What is the NIH funding opportunity being described?
This opportunity is the NIH cooperative agreement program titled "The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01)" with Funding Opportunity Number (FON) PAR 10-208.
Which NIH Institutes or Centers are leading this program?
The program is led by the National Cancer Institute (NCI) in partnership with the National Center for Complementary and Alternative Medicine (NCCAM), now known as the National Center for Complementary and Integrative Health (NCCIH).
What is the central scientific focus of this FOA?
The FOA focuses on the biology at the intersection of diet, the gut microbiome, and cancer. Specifically, it targets how metabolites produced by gut microorganisms from dietary components influence host cells and affect cancer risk, prevention, and disparities.
What types of research questions is the FOA intended to support?
The FOA supports projects that (1) identify and characterize microbially generated metabolites derived from foods or dietary compounds, and (2) determine how those metabolites act in the body at molecular and cellular levels in ways relevant to cancer etiology and prevention.
Is the FOA interested in descriptive metabolite catalogs or mechanistic studies?
The FOA emphasizes mechanistic research. Applicants are expected to go beyond listing which metabolites exist and instead explain what the metabolites do, what pathways they affect, and how those effects could plausibly influence cancer risk or prevention.
What host processes does the FOA highlight as important outcomes to study?
The FOA highlights mechanistic work on how bacterial metabolites affect key host processes tied to carcinogenesis and cancer prevention, including cell proliferation and apoptosis, cytokine production, and broader inflammatory and immunomodulatory pathways.
Does the FOA encourage human intervention research?
Yes. The FOA encourages inclusion of human intervention research where appropriate, particularly to understand variability in metabolite production and downstream biological effects.
Why does the FOA emphasize inter-individual variability in microbial metabolite production?
The FOA emphasizes that different individuals may produce different levels or profiles of microbial metabolites from the same dietary inputs, and those differences could translate into different protective or harmful effects relevant to cancer.
How are racial and ethnic differences addressed in this FOA?
The FOA explicitly highlights studying differences in microbial metabolite production across racial and ethnic groups, linking this focus to cancer health disparities and to understanding whether prevention strategies or dietary recommendations could have different effects in different populations.
What is the long-term prevention relevance described in the FOA?
The FOA frames a long-term goal of improving prevention-relevant knowledge, including identifying who might benefit from specific dietary recommendations, who may not respond as well, and who might be put at risk by certain dietary patterns due to microbiome-mediated metabolism.
Are applications required to use a team science approach?
Yes. The FOA is structured to push team science and requires a multiple principal investigator (multi-PI) model with distinct and complementary expertise across the leadership team.
What expertise areas does the FOA suggest should be represented across the multi-PI team?
The FOA lists example areas such as microbiology, nutrition, cancer biology, analytical chemistry, and genetics as relevant expertise to be represented across the leadership team.
What study types and experimental approaches are allowed?
The FOA allows either clinical or preclinical approaches. That includes human studies, animal models, cell-based mechanistic work, or integrated designs that connect these layers, as long as the work addresses the core mechanistic goal.
What is the core expectation for project design under this FOA?
The core expectation is that the project directly links microbial metabolism of diet-derived components to host biological responses relevant to cancer etiology and prevention, producing actionable mechanistic insight rather than purely descriptive associations.
What is the award mechanism, and what does it imply for NIH involvement?
The FOA uses the NIH U01 cooperative agreement mechanism. Unlike a standard research project grant, a U01 typically involves more active NIH staff participation and is intended to operate as a partnership between investigators and NIH.
Are there collaboration or coordination expectations after award?
Yes. The FOA requires investigators to attend annual meetings with NIH personnel. These meetings are generally used to share progress, harmonize approaches across funded teams, and promote collaboration and cross-fertilization of methods and findings.
Who is eligible to apply for this FOA?
Eligibility is broad and includes public and private institutions of higher education, state governments, for-profit organizations (including small businesses and other for-profits), and nonprofit organizations (including those with or without 501(c)(3) status, with certain distinctions). The FOA also notes eligible federal agencies, non-U.S. (foreign) entities, and regional organizations.
Does the FOA allow international (non-U.S.) applicants?
Yes. The FOA notes that non-U.S. (foreign) entities are among the eligible applicant types, indicating openness to international participation where appropriate.
Is cost sharing or matching required?
No. The FOA does not list a cost sharing or matching requirement.
How is this opportunity categorized from an administrative standpoint?
The opportunity is categorized as discretionary funding and is associated with NIH activity areas mapping to complementary and integrative health research and to cancer cause, prevention, and cancer biology research.
What CFDA numbers are associated with the FOA?
The FOA lists CFDA numbers 93.213, 93.393, and 93.396.
Are awards guaranteed if an application is submitted?
No. Awards are contingent on the availability of funds and the receipt of a sufficient number of strong applications, consistent with standard NIH language about budget and peer review outcomes.
When was this FOA originally posted, and what is its current status?
The original public posting date is May 27, 2010. The FOA is now archived, though it captures the program goals and expectations for applications submitted during its active period.
What is the overall goal of the program described in the FOA?
Overall, the program aims to build a clearer mechanistic understanding of how gut microbes transform dietary components into metabolites that can influence inflammation, immune signaling, and cell fate decisions in ways that matter for cancer. It also aims to translate that biology into prevention-relevant knowledge while rigorously examining variability across individuals and populations to help avoid widening health disparities.
Browse more opportunities from the same category: Education Health
Next opportunity: Office of Elementary and Secondary Education Gulf Coast Recovery Grant Initiative Program CFDA NUmber 84.215C
Previous opportunity: Resource Conservation Challenge Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 10 208
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 10 208) also looked into and applied for these:
| Funding Opportunity |
|---|
| Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows In Nursing Research (F31) Apply for PAR 10 211 Funding Number: PAR 10 211 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Informed Decision Making in Young Adolescents at Risk for HIV/AIDS (R01) Apply for RFA NR 10 008 Funding Number: RFA NR 10 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| PHASE II IICOHRTA AIDS/TB Research Training Program (U2R) Apply for PAR 10 218 Funding Number: PAR 10 218 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| AIDS International Training and Research Program (AITRP) (D43) Apply for PAR 10 219 Funding Number: PAR 10 219 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Core Center of Excellence Grant Program (P30) Apply for PAR 10 220 Funding Number: PAR 10 220 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pathobiology of Emerging Pathogens in Laboratory Animals (R21) Apply for RFA RR 10 004 Funding Number: RFA RR 10 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Pathobiology of Emerging Pathogens in Laboratory Animals (R01) Apply for RFA RR 10 005 Funding Number: RFA RR 10 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Clinical Proteomic Technologies for Cancer Initiative (CPTC) Proteome Characterization Centers (U24) Apply for RFA CA 10 016 Funding Number: RFA CA 10 016 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pre application for a Biomedical Technology Research Center (X02) Apply for PAR 10 224 Funding Number: PAR 10 224 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Biomedical Technology Research Center (P41) Apply for PAR 10 225 Funding Number: PAR 10 225 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Science Education Drug Abuse Partnership Award (R25) Apply for PAR 10 227 Funding Number: PAR 10 227 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Informatics, Coordination and Service Center for the Mutant Mouse Regional Resource Centers (U42) Apply for RFA RR 10 006 Funding Number: RFA RR 10 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Community Clinical Oncology Program Groups (U10) Apply for RFA CA 10 010 Funding Number: RFA CA 10 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Community Clinical Oncology Program Research Bases (U10) Apply for RFA CA 10 011 Funding Number: RFA CA 10 011 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Minority Based Community Clinical Oncology Program Groups (U10) Apply for RFA CA 10 012 Funding Number: RFA CA 10 012 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Clinical and Translational Science Coordinating Center (U54) Apply for RFA RR 10 007 Funding Number: RFA RR 10 007 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Health Promotion Among Racial and Ethnic Minority Males (R21) Apply for PA 10 237 Funding Number: PA 10 237 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Instrument Development for Biomedical Applications (R21) Apply for RFA RR 10 009 Funding Number: RFA RR 10 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $125,000 |
| Nutrition and Alcohol Related Health Outcomes (R01) Apply for PA 10 239 Funding Number: PA 10 239 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Nutrition and Alcohol Related Health Outcomes (R21) Apply for PA 10 241 Funding Number: PA 10 241 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 10 208", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
